Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antioxidant Supplements, Genetics and Chemotherapy Outcomes

NCT03413761 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT03413761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03413761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antioxidant Supplements, Genetics and Chemotherapy Outcomes
Lead sponsor
Roswell Park Cancer Institute
Phase
Observational
Overall status
Completed
Start date
December 18, 2004
Completion date
November 12, 2013
Enrollment
1,771 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

node negative breast cancer, node positive breast cancer